Vitamin B 6 -degradation pathway I has recently been identified in Mesorhizobium loti MAFF303099. Pyridoxine 4-oxidase, an FAD-dependent enzyme, is the first enzyme in this pathway and catalyzes the irreversible oxidation of pyridoxine to pyridoxal. The enzyme was overexpressed in Escherichia coli with a His 6 tag and purified. The recombinant enzyme was crystallized at 277 K by the sitting-drop vapour-diffusion method using PEG 4000 as the precipitant. The crystal, which belonged to space group P2 1 2 1 2 1 with unit-cell parameters a = 62.38, b = 79.44, c = 136.43 Å , diffracted to 2.2 Å resolution. The calculated V M value (3.19 Å 3 Da -1 ) suggested that the asymmetric unit contained one molecule.
Introduction
Pyridoxine 4-oxidase (EC 1.1.3.12) participates in the degradation of vitamin B 6 . It contains FAD and catalyzes the oxidation of pyridoxine to pyridoxal (Fig. 1) . Two pathways for degradation of the free forms of vitamin B 6 (pyridoxine, pyridoxal and pyridoxamine) have been identified in soil microbes that can use vitamin B 6 as a sole source of carbon and nitrogen. Pathway I has been found in Pseudomonas sp. MA-1 (Burg et al., 1960) and Mesorhizobium loti (Yuan et al., 2004) and pathway II in Pseudomonas sp. 1A and Arthrobacter sp. Cr-7 (Nelson & Snell, 1986) . In pathway I, pyridoxine is first oxidized to pyridoxal by pyridoxine 4-oxidase and the pyridoxal is then degraded to succinic semialdehyde, acetic acid, carbon dioxide and ammonia through seven enzymatic steps. In pathway II, pyridoxine is first oxidized to 5-pyridoxal by pyridoxine 5-oxidase and the 5-pyridoxal is then degraded to 2-hydroxymethyl succinic semialdehyde, acetic acid, ammonia and carbon dioxide through five enzymatic steps.
Pyridoxine 4-oxidase has been purified from three bacteria: Pseudomonas sp. MA-1 (Sundaram & Snell, 1969) , Microbacterium luteolum (Kaneda et al., 2002) and M. loti (Yuan et al., 2004) . The enzymes from M. loti and M. luteolum are monomeric and have molecular weights of 55 000 and 54 000, respectively. Pyridoxine 4-oxidase shows high hydrogen-donor specificity: only three pyridinium compounds, for example pyridine 4-methanol, were used as substrates, with very low reactivity (less than 0.15% of the reactivity toward pyridoxine). The enzyme showed no reactivity toward pyridoxine 5 0 -phosphate, which is a precursor of pyridoxal 5 0 -phosphate, a coenzyme form of vitamin B 6 . The amino-acid sequences of the pyridoxine 4-oxidases from M. loti and M. luteolum showed high identity (66%). The sequences showed that the pyridoxine 4-oxidases belong to the glucose-methanol-choline (GMC) oxidoreductase family as they contain two GMC oxidoreductase signature sequences (Prosite).
GMC oxidoreductase C family enzymes are well known FADdependent oxidoreductases and there are 4172 members in the Pfam # 2012 International Union of Crystallography All rights reserved Figure 1 The reaction catalyzed by pyridoxine 4-oxidase.
database (as of October 2010). GMC oxidoreductase family enzymes show diverse catalytic activities towards compounds with a CH-OH group (Cavener, 1992) . Enzymes in this family have a conserved ADP-binding sequence (-fold) near their N-termini, which is involved in FAD binding (Dym & Eisenberg, 2001) , and one or two signature sequences corresponding to residues 94-117 and 268-282, respectively, in M. loti pyridoxine 4-oxidase. In contrast to the N-terminal region (residues 19-44), the function of the C-terminal region (residues 460-520) of the enzymes is not known. Interestingly, pyridoxine 4-oxidase has the signature 2 sequence of the regulator of chromosome condensation (RCC1) protein at residues 500-510. Because the gene encoding pyridoxine 4-oxidase is located next to a gene encoding a repressor protein (PyrR), which may control the expression of the cluster of enzymes involved in the degradation pathway, the function of residues 500-510 should be elucidated.
In order to elucidate the catalytic mechanism and the function of residues 500-510 of pyridoxine 4-oxidase, determination of the threedimensional structure of the enzyme is necessary. Here, we report the crystallization and preliminary X-ray diffraction studies of pyridoxine 4-oxidase from M. loti.
Materials and methods

Overexpression and purification of pyridoxine 4-oxidase
Although the recombinant enzyme has been purified (Yuan et al., 2004) , it could not be crystallized for unknown reasons. Here, pyridoxine 4-oxidase (PNox) with a His 6 tag was prepared and used for crystallization. A mll6785 gene fragment was prepared from pET-mll6785 constructed previously (Yuan et al., 2004) by digestion with XbaI and SalI, and was inserted into pTrc99A (Amersham Biosciences) to yield pTrc99A-mll6785. The His 6 -tag-encoding nucleotide was inserted into the 3 0 -terminus of pTrc99A-mll6785 by inverse PCR with a KOD + Mutagenesis Kit (TOYOBO) to yield pTrc99A-mll6785-his according to the instruction manual. The primers used were 5 0 -CACCACCACCACCACCACTAAGTCGACCTGCAGGC-ATGCAAGCTT-3 0 (pTrc99A-mll6785-his-F) and 5 0 -GTACTGTCG-GGCGAAAGTCTCG-3 0 (pTrc99A-mll6785-his-R). Escherichia coli JM109 cells were co-transformed with pTrc99A-mll6785-his and pKY206 carrying chaperonin genes (Mizobata et al., 1992) . The transformed cells were grown in 5 ml LB medium containing ampicillin (50 mg ml À1 ), tetracycline (12.5 mg ml À1 ) and riboflavin (50 mg ml À1 ) at 295 K for 24 h. The broth was then transferred to 200 ml of the same medium and the inoculated cells were grown at 296 K for 48 h. The cells were harvested by centrifugation at 8000 rev min À1 for 10 min at 277 K and washed with 0.9%(w/v) NaCl. The harvested cells (2 g wet weight) were suspended in 20 ml buffer A [20 mM potassium phosphate buffer pH 8.0, 10%(w/v) glycerol, 5 mM FAD, 10 mM -mercaptoethanol, 0.01%(v/v) Tween 20] containing 300 mM NaCl and 10 mM imidazole. The suspension was sonicated on ice for 4 min with a model W-220 sonicator (Heat Systems-Ultrasonics, Farmingdale, New York, USA). A cell extract was obtained by centrifugation at 10 000g for 10 min at 277 K; the precipitate was resuspended again in buffer A, sonicated and centrifuged. The combined supernatants were used as the crude extract. The crude extract was applied onto an Ni-NTA agarose column (1.6 Â 10 cm, Qiagen) equilibrated with buffer A containing 300 mM NaCl and 20 mM imidazole. The column was washed until the A 280 of the eluted solution decreased to below 0.01 and the enzyme was then eluted with buffer A containing 300 mM NaCl and 100 mM imidazole. The eluted enzyme solution was thoroughly dialyzed against buffer A and then applied onto a QA52 column (1.6 Â 2.5 cm, Whatman) equili-brated with buffer A. The enzyme was eluted with buffer A containing 0.2 M NaCl. The eluted enzyme solution was thoroughly dialyzed at 277 K against the crystallization buffer [50 mM Tris-HCl pH 8.0, 10%(w/v) glycerol, 5 mM FAD, 0.1%(v/v) -mercaptoethanol, 0.01%(v/v) Tween 20].
Enzyme assay
PNox activity was determined as described previously (Yuan et al., 2004) . Briefly, a reaction mixture (1 ml) consisting of 0.1 M Tris-HCl pH 8.0, 5 mM pyridoxine, 5 mM FAD and the enzyme was incubated aerobically for 10 min at 303 K. The yellow colour produced by the Schiff base formed by the reaction between pyridoxal and Tris base was measured by the absorbance at 415 nm. One unit of enzyme was defined as the amount that catalysed the formation of 1 mmol pyridoxal per minute. Protein concentrations were measured by the protein-dye method (Bradford, 1976) .
Crystallization and X-ray analysis
The purified enzyme was concentrated to 10 mg ml -1 using an Amicon Ultra-4 filter (Millipore, Billerica, USA). Crystallization conditions were screened using the Crystallization Basic Kit for Proteins (Sigma-Aldrich Chemie, Steinheim, Germany) and Wizard I and II (Emerald BioSystems, Washington, USA) by the sitting-drop vapour-diffusion method. A mixture consisting of 2 ml enzyme solution and 2 ml reservoir solution was equilibrated against 100 ml SDS-PAGE analysis of the purified pyridoxine 4-oxidase. Lane 1, molecular-weight markers (labelled in kDa). Lane 2, purified enzyme used for crystallization (4 mg).
A PNox crystal was picked out from a droplet and placed into a nitrogen-gas stream at 100 K without cryoprotectant treatment. X-ray diffraction images were obtained using an in-house Bruker Hi-Star multi-wire area detector coupled to a MAC Science M18XHF rotating-anode generator at Kyoto University. The final diffraction data for the selected crystal were collected at 100 K in a nitrogen-gas stream using an ADSC Quantum 315 CCD detector and synchrotron radiation of wavelength 1.00 Å at the BL38B1 station of SPring-8 (Hyogo, Japan). The crystal-to-detector distance was set to 300.0 mm. Oscillation images of 1.0 were recorded with an exposure time of 20 s.
Results and discussion
His 6 -tagged pyridoxine 4-oxidase was successfully overexpressed in E. coli and purified, with significant enzyme activity being maintained. The results of SDS-PAGE analysis of the purified enzyme are shown in Fig. 2 .
Crystals suitable for X-ray data collection were obtained (Fig. 3) . The crystals yielded good diffraction images, as shown in Fig. 4 . Diffraction data were obtained from the crystal in the resolution range 50.00-2.20 Å and were processed using the HKL-2000 program package (DENZO and SCALEPACK; Otwinowski & Minor, 1997) . The crystal parameters and diffraction data statistics are summarized in Table 1 . The data set was 99.8% complete at the resolution limit of 2.2 Å . The V M value (the crystal volume per unit protein molecular weight; Matthews, 1968 ) was calculated to be 3.19 Å 3 Da À1 assuming the presence of one molecule of the enzyme in an asymmetric unit, with the solvent content being 61.42%. The V M value and solvent content lie within the ranges usually found for protein crystals. The molecular-replacement method was performed using the MOLREP program from the CCP4 program suite (Winn et al., 2011) with the structures of the glucose oxidases from Aspergillus niger and Penicillium amagasakiense (PDB entries 1cf3 and 1gpe; Wohlfahrt et al., 1999) and of cholesterol oxidase (PDB entry 3gyi; Lyubimov et al., 2009) as models, but a plausible solution could not be obtained.
We are currently using other available GMC oxidoreductase structures as search models for molecular replacement and independently preparing heavy-atom derivatives of the enzyme. Crystal of pyridoxine 4-oxidase. The scale bar is 0.2 mm in length.
Figure 4
Diffraction image of pyridoxine 4-oxidase. The ring indicates a resolution of 2.2 Å . 
